These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 26985644)

  • 1. Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact.
    Coleman O; Henry M; McVey G; Clynes M; Moriarty M; Meleady P
    Expert Rev Proteomics; 2016; 13(4):383-94. PubMed ID: 26985644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic cancer: diagnosis and treatments.
    Li HY; Cui ZM; Chen J; Guo XZ; Li YY
    Tumour Biol; 2015 Mar; 36(3):1375-84. PubMed ID: 25680410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in proteomic profiling of pancreatic ductal adenocarcinoma and the road ahead.
    Kim H; Park J; Wang JI; Kim Y
    Expert Rev Proteomics; 2017 Nov; 14(11):963-971. PubMed ID: 28926720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can protein science solve the unmet needs in pancreatic cancer diagnosis and therapy?
    Ansari D; Sambergs F; Johansson L; Andersson R
    Expert Rev Proteomics; 2017 Jun; 14(6):469-471. PubMed ID: 28388239
    [No Abstract]   [Full Text] [Related]  

  • 5. Proteomic analysis of pancreatic ductal adenocarcinoma.
    Meleady P; Abdul Rahman R; Henry M; Moriarty M; Clynes M
    Expert Rev Proteomics; 2020 Jun; 17(6):453-467. PubMed ID: 32755290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Validation of Novel Subtype-Specific Protein Biomarkers in Pancreatic Ductal Adenocarcinoma.
    Kuhlmann L; Nadler WM; Kerner A; Hanke SA; Noll EM; Eisen C; Espinet E; Vogel V; Trumpp A; Sprick MR; Roesli CP
    Pancreas; 2017 Mar; 46(3):311-322. PubMed ID: 27846146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteome-based biomarkers in pancreatic cancer.
    Sun C; Rosendahl AH; Ansari D; Andersson R
    World J Gastroenterol; 2011 Nov; 17(44):4845-52. PubMed ID: 22171124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
    Shukla HD; Mahmood J; Vujaskovic Z
    Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances of Functional Proteomics in Gastrointestinal Cancers- a Path towards the Identification of Candidate Diagnostic, Prognostic, and Therapeutic Molecular Biomarkers.
    Abyadeh M; Meyfour A; Gupta V; Zabet Moghaddam M; Fitzhenry MJ; Shahbazian S; Hosseini Salekdeh G; Mirzaei M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Biomarkers of Pancreatic Intraepithelial Neoplasia and Their Implications in Early Diagnosis and Therapeutic Intervention of Pancreatic Cancer.
    Guo J; Xie K; Zheng S
    Int J Biol Sci; 2016; 12(3):292-301. PubMed ID: 26929736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoproteins and glycoproteomics in pancreatic cancer.
    Pan S; Brentnall TA; Chen R
    World J Gastroenterol; 2016 Nov; 22(42):9288-9299. PubMed ID: 27895417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics of ovarian cancer: functional insights and clinical applications.
    Elzek MA; Rodland KD
    Cancer Metastasis Rev; 2015 Mar; 34(1):83-96. PubMed ID: 25736266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic profiling predicts drug response to novel targeted anticancer therapeutics.
    Lin F; Li Z; Hua Y; Lim YP
    Expert Rev Proteomics; 2016; 13(4):411-20. PubMed ID: 26954459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.
    Zhou L; Wang K; Li Q; Nice EC; Zhang H; Huang C
    Expert Rev Proteomics; 2016; 13(4):367-81. PubMed ID: 26923776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential for proteomic approaches in determining efficacy biomarkers following administration of fish oils rich in omega-3 fatty acids: application in pancreatic cancers.
    Runau F; Arshad A; Isherwood J; Norris L; Howells L; Metcalfe M; Dennison A
    Nutr Clin Pract; 2015 Jun; 30(3):363-70. PubMed ID: 25616520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unbiased Quantitative Proteomics of Organoid Models of Pancreatic Cancer.
    Low RRJ; Fung KY; Dagley LF; Yousef J; Emery-Corbin SJ; Putoczki TL
    Methods Mol Biol; 2024; 2823():77-93. PubMed ID: 39052215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and Clinical Proteomic Exploration of Pancreatic Cancer.
    Huang P; Gao W; Fu C; Tian R
    Mol Cell Proteomics; 2023 Jul; 22(7):100575. PubMed ID: 37209817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic profiling of pancreatic cancer for biomarker discovery.
    Chen R; Pan S; Brentnall TA; Aebersold R
    Mol Cell Proteomics; 2005 Apr; 4(4):523-33. PubMed ID: 15684406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in proteomically subtyping pancreatic ductal adenocarcinomas and their potential clinical impact.
    Roesli C
    Expert Rev Proteomics; 2015 Feb; 12(1):5-8. PubMed ID: 25407217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategies for discovering novel pancreatic cancer biomarkers.
    Chan A; Diamandis EP; Blasutig IM
    J Proteomics; 2013 Apr; 81():126-34. PubMed ID: 23026552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.